Rapid recovery with oral zinc sulphate in deferoxamine-induced presumed optic neuropathy and hearing loss.
Pinna
A
A
Institute of Ophthalmology, University of Sassari, Italy. oculist@ssmain.uniss.it
Corda
L
L
Carta
F
F
D000284:Administration, Oral; D000328:Adult; D001252:Astringents / Q000627:therapeutic use*; D002614:Chelating Agents / Q000009:adverse effects*; D003676:Deferoxamine / Q000009:adverse effects*; D005260:Female; D006319:Hearing Loss, Sensorineural / Q000139:chemically induced / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D019190:Iron Overload / Q000188:drug therapy; D009901:Optic Nerve Diseases / Q000139:chemically induced / Q000188:drug therapy* / Q000503:physiopathology; D019287:Zinc Sulfate / Q000627:therapeutic use*
D001252:Astringents; D002614:Chelating Agents; D019287:Zinc Sulfate; D003676:Deferoxamine